Press Releases

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008

October 21, 2008

Ironwood Presents Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation

October 7, 2008

Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients with Irritable Bowel Syndrome with Constipation

October 6, 2008

Ironwood and Collaborators Present Preclinical Data Demonstrating that Cyclic GMP Alleviates Intestinal Pain

October 1, 2008

Ironwood Raises $50 Million to Advance Linaclotide Through Phase 3

September 23, 2008

Ironwood and Forest to Present Positive Data from Linaclotide Phase 2b IBS-C Study at ACG Annual Scientific Conference

May 20, 2008

Ironwood Pharmaceuticals and Forest Laboratories Announce Presentation of Linaclotide Phase 2b Chronic Constipation Study Results

April 7, 2008

Microbia Announces Name Change to Ironwood Pharmaceuticals

March 31, 2008

Microbia Appoints Halley Gilbert as Vice President, General Counsel

March 4, 2008

Microbia and Forest Laboratories Announce Preliminary Results of Linaclotide Phase 2B Studies